Junxun Ma

Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Pengfei Cui, Zhefeng Liu, Guoqiang Wang et al. · Cancer Medicine · 2018 · 113 citations · Full text

Medicine, Immunology, Oncology +15

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion

Nan Du, Xiaosong Li, Fang Li et al. · Oncology Reports · 2013 · 88 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Zhibo Zhang, Runzhe Chen, Ye Li et al. · Frontiers in Immunology · 2020 · 55 citations · Full text

Medicine, Immunology, Oncology +17

Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade

Jin Shang, Han Xiao, Haoran Zha et al. · Frontiers in Oncology · 2021 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

Danyang Sun, Junxun Ma, Jinliang Wang et al. · Cancer Immunology Immunotherapy · 2019 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17